Lemeneva L N, Chertkov J L
Exp Hematol. 1976 Jul;4(4):209-20.
Injection of various parental strain hemic cells reduces the ability of the F1 hybrid to resist growth of grafted hemopoietic tissue from the same parent strain. Such an effect can be exerted by cells from lymph nodes, spleen, bone marrow, or thymus, the peritoneal macrophages, and the peripheral blood leukocytes. Embryonic and adult liver cells or blood erythrocytes do not inhibit hybrid resistance. It is assumed that hemic cells inhibit hybrid resistance through an effect on the hemopoietic microenvironment. The mechanism of this effect cannot be considered the result of a graft-versus-host reaction since lymphoid cells which are "immune" or "tolerant" to the hybrid antigens possess inhibitory activity similar to that of intact lymphoid cells. The hybrid resistance inhibitory cells maintain the inability of "parent-in-F1 hybrid" type chimeras to express hybrid resistance for at least 2 months.
注射各种亲本品系的血细胞会降低F1杂种抵抗来自同一亲本品系的移植造血组织生长的能力。淋巴结、脾脏、骨髓、胸腺的细胞、腹腔巨噬细胞以及外周血白细胞均可产生这种效应。胚胎和成年肝细胞或血液红细胞不会抑制杂种抵抗力。据推测,血细胞通过对造血微环境的作用来抑制杂种抵抗力。这种效应的机制不能被认为是移植物抗宿主反应的结果,因为对杂种抗原有“免疫”或“耐受”的淋巴细胞具有与完整淋巴细胞相似的抑制活性。杂种抵抗力抑制细胞使“亲本品系-F1杂种”型嵌合体至少2个月内无法表达杂种抵抗力。